Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer (Q33710557)

28 July 2017

title

Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer (English)

1 reference

28 July 2017

1 reference

9

Luigi Cataliotti

1 reference

28 July 2017

14

Emiel J T Rutgers

1 reference

28 July 2017

Marieke E Straver

1

1 reference

28 July 2017

Philip Meijnen

2

1 reference

28 July 2017

Geertjan van Tienhoven

3

1 reference

28 July 2017

Cornelis J H van de Velde

4

1 reference

28 July 2017

Robert E Mansel

5

1 reference

28 July 2017

Jan Bogaerts

6

1 reference

28 July 2017

Gaston Demonty

7

1 reference

28 July 2017

Nicole Duez

8

1 reference

28 July 2017

Jean Klinkenbijl

10

1 reference

28 July 2017

Helen A Westenberg

11

1 reference

28 July 2017

Huub van der Mijle

12

1 reference

28 July 2017

Coen Hurkmans

13

1 reference

28 July 2017

language of work or name

English

0 references

publication date

28 December 2009

1 reference

Journal of Clinical Oncology

28 July 2017

published in

1 reference

28 July 2017

volume

28

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

731-737

1 reference

Clinical application of the 70-gene profile: the MINDACT trial

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Gene expression profiling predicts clinical outcome of breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Operable cancer of the breast.A controlled clinical trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834391

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

30 October 2018

1 reference

12 December 2020

Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run

1 reference

12 December 2020

The Cardiff-St Mary's trial

1 reference

12 December 2020

A clinical trial in the management of operable cancer of the breast

1 reference

12 December 2020

Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working Party

1 reference

12 December 2020

Manchester regional breast study--5 and 10 year results

1 reference

12 December 2020

Incidence of breast carcinoma-related lymphedema

1 reference

12 December 2020

Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial

1 reference

12 December 2020

Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.21.7554

1 reference

28 July 2017

1 reference

28 July 2017

1 reference